| 2021-04-01 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, General Counsel | 69,216 0.1046% | $82.47 | $5.71M | +41.31% | |
| 2021-02-09 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, General Counsel | 22,978 0.0175% | $37.50 | $861,675 | +54.44% | |
| 2021-02-01 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, General Counsel | 109,318 0.1623% | $63.99 | $7M | +76.35% | |
| 2021-01-05 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, General Counsel | 4,156 0.0057% | $55.86 | $232,154 | +85.43% | |
| 2020-12-01 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, General Counsel | 6,728 0.0121% | $38.21 | $257,050 | +110.61% | |
| 2020-11-18 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, General Counsel | 1,248 0.0023% | $35.00 | $43,680 | +129.73% | |
| 2020-11-16 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, General Counsel | 12,058 0.0215% | $34.29 | $413,457 | +127% | |
| 2020-11-04 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, General Counsel | 6,728 0.0124% | $28.00 | $188,384 | +177.2% | |
| 2020-10-15 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, General Counsel | 11,230 0.02% | $24.20 | $271,766 | +197.9% | |
| 2020-09-15 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, General Counsel | 11,230 0.0181% | $21.04 | $236,279 | +205.81% | |
| 2020-08-18 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, General Counsel | 11,230 0.0189% | $21.00 | $235,830 | +209.13% | |
| 2020-07-15 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, General Counsel | 11,230 0.0192% | $22.70 | $254,921 | +169.88% | |
| 2020-06-16 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, General Counsel | 11,230 0.0209% | $21.00 | $235,830 | +149.67% | |
| 2020-05-26 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, General Counsel | 11,230 0.0234% | $21.21 | $238,188 | +82.25% |